A. Kabour et al., ANGIOTENSIN-II (AII)-INDUCED MYOCYTE NECROSIS - ROLE OF THE AII-RECEPTOR, Journal of cardiovascular pharmacology, 23(4), 1994, pp. 547-553
Pathophysiologic levels of angiotensin II (AII) produce myocyte necros
is. We investigated whether the cardiotoxic effects of AII are mediate
d through the AII type 1 receptor (AT1). Seven groups (4-6 rats/group)
were given AII (150 ng/min) alone or in combination with the AT1 anta
gonist losartan (7.5 mg/day). Groups were as follows: Al, A4, and L1 r
eceived AII for 2 days; A2 and L2 received AII for 9 days; and A3 and
L3 received AII for 2 days and again for 2 days 5 days later. Groups L
1, L2, and L3 also received losartan 2 days before and throughout the
AII infusion period. AII rats except those in group A4 were killed at
the end of their respective infusion periods (group A4 rats were kille
d 7 days after infusion). Group A1 had multifocal areas of recent myoc
yte injury. Groups A2 and A4 had multifocal scars and only a few new a
reas of myocyte damage. Group A3, in addition to scar formation, had d
e novo areas of necrosis. There was no evidence of myocyte necrosis in
groups L1, L2, and L3. Thus, AII-related myocyte necrosis is receptor
mediated. Moreover, a chronic increase in AII appears to cause cardio
protective downregulation of the AT1 re ceptor.